Hiroshi Arima, Momoko Nishikori, Yasuyuki Otsuka, Kiyotaka Izumi, Wataru Kishimoto, Akifumi Takaori-Kondo (Department of Hematology and Oncology, Kyoto University, Kyoto, Japan)

Kana Sakamoto^1,2, Ryohei Katayama³, Reimi Asaka^1,4, Seiji Sakata¹, Satoko Baba¹, Hideki Nakasone², Sumie Koike³, Naoko Tsuyama⁴, Akito Dobashi¹, Makoto Sasaki⁵, Ryo Ichinohasama⁶, Emi Takakuwa⁷, Rie Yamazaki⁸, Jun Takizawa⁹, Takahiro Maeda¹⁰, Miwako Narita¹¹, Koji Izutsu¹², Yoshinobu Kanda², Koichi Ohshima¹³, Kengo Takeuchi^1,4 (1.Pathology Project for Molecular Targets, Cancer Institute, JFCR, Tokyo, Japan, 2.Div. Hematol., Jichi Medical University Saitama Medical Center, Saitama, Japan, 3.Division of Experimental Chemotherapy, Cancer Chemotherapy Center, JFCR, Tokyo, Japan, 4.Division of Pathology, The Cancer Institute, JFCR, Tokyo, Japan, 5.Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan, 6.Dept. Hematopathology, Tohoku University Graduate School of Medicine, Sendai, Japan, 7.Dept. Surg. Pathol., Hokkaido Univ. Hosp., Sapporo, Japan, 8.Division of Hematology, Keio University School of Medicine, Tokyo, Japan, 9.Dept. Hematology/Endocrinology/Metabolism, Niigata Univ. Faculty of Medicine, Niigata, Japan, 10.Department of General Medicine, Nagasaki University Graduate School, Nagasaki, Japan, 11.Laboratory of Hematology and Oncology, Niigata University, Niigata, Japan, 12.Department of Hematology, National Cancer Center Hospital, Tokyo, Japan, 13.Department of Pathology, School of Medicine, Kurume University, Kurume, Japan)

Nobuhiko Yamauchi^1,2, Junichiro Yuda^1,2, Yuki Fujioka², Joji Nagasaki², Miki Yamazaki², Yosuke Togashi², Yosuke Minami¹, Hiroyoshi Nishikawa² (1.Department of Hematology, National Cancer Center East Hospital, 2.Division of Cancer Immunology, National Cancer Center)

Tomoyasu Jo¹, Momoko Nishikori¹, Yoshiteru Sasaki², Yasunori Kogure^3,4, Keisuke Kataoka^3,4, Seishi Ogawa^3,5, Kazuhiro Iwai², Akifumi Takaori-Kondo¹ (1.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 2.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 3.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 4.Division of Molecular Oncology, NCCRI, Tokyo, Japan, 5.Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden)

Jutatip Panaampon, Ryusho Kariya, Seiji Okada (Division of Hematopoiesis, Center for AIDS Research, Kumamoto University, Kumamoto, Japan)

Hamidah Muhamad¹, Narittee Sukswai², Kitsada Wudhikarn¹ (1.Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Kingdom of Thailand, 2.Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Kingdom of Thailand)